Roche Announces FDA Clearance for POC Glucose Monitoring Meter

Roche has announced that is has received clearance from the US Food and Drug Administration (FDA) for its Accu-Chek® Nano SmartView blood glucose monitoring system. The new meter offers improved functions such as customizable test reminders, pre and post-meal markers, and average glucose calculation.

The new Accu-Chek Nano meter is smaller than a credit card, has a large brilliant backlit display and is the first no-code meter in the Accu-Chek product family. The meter uses Accu-Chek® SmartView test strips and can now be calibrated to the respective test strips without coding or need for a code key. The product will be available to customers in the first half of 2012.

"We are very excited to bring this latest blood glucose monitoring technology to the United States," said Luc Vierstraete, Global Head of Roche Diabetes Care. "The Accu-Chek Nano meter is the newest advancement in Roche's more than 35-year commitment to bring state-of-the-art innovations to people with diabetes and their caregivers, and continues our promise to enabling optimal diabetes management. This new system will help us to further leverage and enhance our position in this important market."

"The Accu-Chek Nano blood glucose meter will appeal to those who prefer a small, discreet meter with maximum performance and is Roche Diabetes Care's latest innovation aimed at enabling diabetes success for our customers and their health care team," said Marc Gibeley, Head of Roche Diabetes Care North America. "It is easy-to-use and will help people with diabetes regularly check their blood glucose levels before making informed therapy and lifestyle adjustments. We look forward to its launch later this year."